Funded Artificial Intelligence Startups in Dublin
Among the 35 funded AI entries shown (sorted by round date descending), the largest disclosed round is Opkey’s $47M on 2024-08-22.
Among the 35 funded AI entries shown (sorted by round date descending), the largest disclosed round is Opkey’s $47M on 2024-08-22. That figure sits far above the next-highest disclosed amounts of $42M (Nuritas, 2024-12-20) and $52M (Kitman Labs, 2021-11-04), and dwarfs most other rounds clustered in the sub-$10M range (for example, $18M Deciphex on 2025-10-02 and $11M Ubotica on 2026-06-23). A second visible pattern is geographic concentration: Dublin, Ireland accounts for the majority of listed companies, with a smaller but consistent presence of US-based Dublin locations (e.g., Opkey in Dublin, California; AEye in Dublin, California; Amber Solutions in Dublin, California; ReasonBlocks in Dublin, California; Checkmate AI in Dublin, Ohio). Temporally, rounds span 2020-08-11 (Antikytera e-Technologies) through 2026-06-23 (Ubotica), with several new rounds landing in June 2026 (Ubotica and Whyze Health on 2026-06-23; ReasonBlocks on 2026-06-16; Midnight Labs on 2026-06-04), indicating a recent uptick within this slice.
Stage and disclosure are mixed: multiple entries are “Series Unknown” or “undisclosed” (including Whyze Health on 2026-06-23 with undisclosed, Midnight Labs on 2026-06-04 with undisclosed, and Tao Climate on 2025-02-07 with undisclosed). The list also includes several high late-stage rounds (e.g., Nuritas Series C at $42M on 2024-12-20; Kitman Labs Series C at $52M on 2021-11-04; Opkey Series B at $47M on 2024-08-22), while earlier stages show many rounds at $1M–$2M (such as MARC $1M on 2026-02-10; AICertified $1M on 2026-01-15; Numra $2M on 2024-05-16).
Most recent rounds
35 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Dublin AI set, and how extreme is it versus the rest?
Opkey’s $47M (Series B) on 2024-08-22 is the largest disclosed amount among the rows shown. It’s substantially above most other disclosed rounds, including $42M for Nuritas (2024-12-20) and $18M for Deciphex (2025-10-02), while several entries cluster around $1M–$2M (e.g., MARC $1M on 2026-02-10; Numra $2M on 2024-05-16).
Are there any tight time windows where multiple rounds appear concentrated?
Yes: June 2026 has multiple entries with dates close together, including Ubotica and Whyze Health on 2026-06-23, ReasonBlocks on 2026-06-16, and Midnight Labs on 2026-06-04. In contrast, the earlier historical edge runs back to 2020-08-11 (Antikytera e-Technologies), so the distribution includes both a recent cluster and a long tail.
Which geographies show up repeatedly, and do US 'Dublin' locations change the pattern?
Dublin, Ireland is the dominant location across the list (for example, Ubotica on 2026-06-23; Deciphex on 2025-10-02; Nuritas on 2024-12-20). A smaller share of entries use US 'Dublin' cities, such as Opkey (Dublin, California $47M on 2024-08-22), AEye (Dublin, California $50M on 2024-07-29), ReasonBlocks (Dublin, California $500K on 2026-06-16), and Checkmate AI (Dublin, Ohio $40K on 2026-06-03).
How much of the round data is missing or non-specific (Series Unknown / undisclosed amounts), and does it affect outlier detection?
Several rows are not directly comparable because amounts or stages are missing. Examples include Whyze Health (Seed, 2026-06-23) with an undisclosed amount and Midnight Labs (Seed, 2026-06-04) with an undisclosed amount; there are also multiple “Series Unknown” classifications like Ubotica (2026-06-23) and Nexus Inclusion (2026-05-22). When focusing only on disclosed amounts, the $47M Opkey round stands apart, but undisclosed rows limit how sharply the lowest end can be assessed.
What stage mix dominates, based on the rows shown?
Earlier-stage labels appear frequently: Seed entries include Better Futures ($700K on 2026-05-20), Assiduous ($1M on 2025-04-15), and inspeq ai ($1M on 2024-05-28). Late-stage rounds exist but are fewer and larger, such as Nuritas Series C at $42M (2024-12-20), Kitman Labs Series C at $52M (2021-11-04), and Opkey Series B at $47M (2024-08-22).
Are there any low-amount disclosed rounds that look like true small-end outliers?
Yes: Checkmate AI is disclosed at $40K on 2026-06-03, which is far below most other disclosed entries that commonly sit around $500K–$2M (e.g., ReasonBlocks $500K on 2026-06-16; Meso $580K on 2025-12-02; Amethyst Care $540K on 2024-07-15). Because some rows are undisclosed (e.g., Whyze Health and Midnight Labs), this small-end call is based only on disclosed amounts.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.